Statistics
Publications
1
Citations
157
H-Index
1
Active since
2018
Affiliations
AstraZeneca (United States)(Current)
Maximillian W. Schenk is an author at AstraZeneca (United States) specializing in small cell lung cancer treatment, targeted therapy, and wee1 kinase inhibition.
Publications per year
2018–2018
1
1
1–1 of 1